The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.50
Bid: 40.00
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 5.00 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 43.50
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Jan 2014 16:24

RNS Number : 9893X
Ebiquity PLC
17 January 2014
 



Ebiquity plc

("the Company")

 

Director dealings

 

The Company announces that the following options (the "Options") to acquire ordinary shares of 25p each in the Company ("Ordinary Shares") have been issued to the directors listed below. It was intended that these options would have been issued during 2013 - in parallel with other awards granted under the Company's Executive Share Option Plan - but for the directors being in possession of inside information which precluded them from dealing. The exercise price of each Option is 25p per Ordinary Share.

 

Name of director

Number of options

Michael Greenlees

350,000

Nick Manning

200,000

Andrew Beach

100,000

 

The vesting of the Options will be conditional on the satisfaction of performance criteria relating to the rate of compound growth of the Company's diluted adjusted earnings per share ("EPS") over the three year period ending 30 April 2016 (the "Performance Period"). Growth will be measured against the reference adjusted diluted EPS for the year ended 30 April 2013.

 

Compound EPS growth over the Performance Period of 15% per annum or more will result in all of the Options vesting. Compound EPS growth of 5% per annum over the Performance Period will vest one fifth of the Options. None of the Options will vest if compound EPS growth over the Performance Period is less than 5% per annum. The Options will vest on a straight-line basis where compound EPS growth over the Performance Period is between 5% per annum and 15% per annum.

 

17 January 2014

 

Enquiries:

 

Ebiquity plc

Andrew Beach (CFO)

 

0207 650 9600

Numis Securities Limited

Nick Westlake (NOMAD)

David Poutney, James Serjeant (Corporate Broker)

0207 260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUWPGUPCGQM
Date   Source Headline
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:05 pmRNSHolding(s) in Company
21st Mar 20183:00 pmRNSDividend Declaration
21st Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20187:00 amRNSDirectorate Change
19th Feb 20187:00 amRNSIssue of Shares
13th Feb 20182:00 pmRNSDirector/PDMR dealing and grant of options
13th Feb 20187:00 amRNS£26m disposal and pre-close trading statement
2nd Jan 20184:45 pmRNSTotal Voting Rights
19th Dec 20177:00 amRNSDirectorate Change
28th Nov 201710:15 amRNSHolding(s) in Company
17th Nov 201712:01 pmRNSIssue of Shares
8th Nov 20173:00 pmRNSIssue of Shares
26th Sep 20177:00 amRNSInterim Results
19th Sep 20175:50 pmRNSHolding(s) in Company
31st Aug 20172:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNSIssue of Shares
21st Aug 20177:00 amRNSIssue of Shares
17th Aug 20178:52 amRNSIssue of Shares
8th Aug 20177:00 amRNSExercise of Share Options and dealing by PDMR
3rd Aug 20177:00 amRNSInterim trading statement
11th Jul 20177:00 amRNSEbiquity Launches Total View Attribution service
4th Jul 20177:00 amRNSEbiquity Launches Media Transparency Score tool
31st May 20171:00 pmRNSTotal Voting Rights
11th May 20175:05 pmRNSExercise of Share Options
10th May 201711:16 amRNSResult of AGM
2nd May 201711:05 amRNSDirector/PDMR Shareholding
21st Apr 20173:00 pmRNSAwards extension
20th Apr 20177:00 amRNSEbiquity launches 'Portfolio Digital' in the UK
18th Apr 201710:05 amRNSAnnual Report
29th Mar 201711:02 amRNSDividend Declaration
28th Mar 20177:00 amRNSFinal Results
10th Mar 20173:30 pmRNSHolding(s) in Company
26th Jan 20177:00 amRNSPre-close trading statement
2nd Dec 201612:15 pmRNSDeferred Consideration/Issue of Ordinary Shares
11th Nov 20162:48 pmRNSHolding(s) in Company
14th Oct 201612:30 pmRNSRe Directorate
6th Oct 20167:00 amRNSLaunch of Strategic Media Consultancy service
28th Sep 20167:00 amRNSInterim Results
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.